Amgen (AMGN) Long-Term Debt Issuances (2009 - 2026)

Amgen's Long-Term Debt Issuances history runs 13 years deep, the most recent figure standing at $4.0 billion for Q1 2026.

• In Q1 2026, Long-Term Debt Issuances changed N/A year-over-year to $4.0 billion; the TTM figure through Mar 2026 stood at $4.0 billion (changed N/A YoY), while the FY2023 annual figure was $27.8 billion, up 301.46% from the prior year.
• Long-Term Debt Issuances was $4.0 billion for Q1 2026 at Amgen, down from $4.0 billion in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $23.8 billion in Q1 2023 to a low of -$19.0 million in Q4 2022.
• Historically, Long-Term Debt Issuances has averaged $4.3 billion across 3 years, with a median of $3.0 billion in 2022.
• The sharpest annual moves came in 2022 and 2023: Long-Term Debt Issuances slumped 1800.0% in 2022, then jumped 21131.58% in 2023.
• A 3-year view of Long-Term Debt Issuances shows it stood at -$19.0 million in 2022, then surged by 21131.58% to $4.0 billion in 2023, then fell by 0.8% to $4.0 billion in 2026.
• The last three Long-Term Debt Issuances figures came in at $4.0 billion (Q1 2026), $4.0 billion (Q4 2023), and $1.0 million (Q3 2023), per Business Quant data.